ChemoCentryx Competitors and Similar CompaniesClear all
ChemoCentryx's competitors and similar companies include Pharmstandard and NATCO Pharma.
 ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. |  NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). | |
Founding Date | Founding Date 1997 | Founding Date 2003 | Founding Date 1981 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations San Carlos, US HQ | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN |
Employees | Employees 51 | Employees 1,77814% increase | Employees 4,016 |
Financial | |||
Revenue (est.) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) ₽152.1b (FY, 2024) | Revenue (est.) ₹44.1b (FY, 2025) |
Cost of goods | Cost of goods $302k (FY, 2021) | Cost of goods ₽117b (FY, 2024) | Cost of goods ₹7.5b (FY, 2025) |
Gross profit | Gross profit $31.9m (FY, 2021) | Gross profit ₽35.2b (FY, 2024) | Gross profit ₹37b (FY, 2025) |
Net income | Net income ($131.8m) (FY, 2021) | Net income ₽22.7b (FY, 2024) | Net income ₹18.8b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Pharmstandard
HQ
Dolgoprudny, RU
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
View companyNATCO Pharma
HQ
Hyderabad, IN
Employees
4,016
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View company